共 50 条
Dupilumab reduces OCS use and improves lung function in patients with severe OCS-dependent asthma
被引:0
|作者:
Gurnell, M.
[1
]
Domingo, C.
[2
,3
]
Rabe, K. F.
[4
,5
]
Menzies-Gow, A.
[6
]
Price, D.
[7
]
Brusselle, G.
[8
]
Wechsler, M. E.
[9
]
Xia, C.
[10
]
Pandit-Abid, N.
[11
]
Gall, R.
[10
]
Jacob-Nara, J. A.
[11
]
Rowe, P. J.
[11
]
Deniz, Y.
[10
]
Siddiqui, S.
[10
]
机构:
[1] Univ Cambridge, Wellcome MRC Inst Metab Sci, Cambridge, England
[2] Corp Sanitaria Parc Tauli, Sabadell, Spain
[3] Autonomous Univ Barcelona, Barcelona, Spain
[4] LungenClin Grosshansdorf, Airway Res Ctr North ARCN, Grosshansdorf, Germany
[5] German Ctr Lung Res DZL, Grosshansdorf, Germany
[6] Royal Brompton & Harefield Hosp, London, England
[7] Observat & Pragmat Res Inst, Midview City, Singapore
[8] Univ Ghent, Ghent, Belgium
[9] Natl Jewish Hlth, Denver, CO USA
[10] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[11] Sanofi, Bridgewater, NJ USA
关键词:
Asthma;
Adults;
Treatments;
D O I:
10.1183/13993003.congress-2022.3620
中图分类号:
R56 [呼吸系及胸部疾病];
学科分类号:
摘要:
3620
引用
收藏
页数:2
相关论文